Skip to main content
AmigoFish

The people who stayed with the problem

From The Top Line · · 25 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

The 2026 Fierce 50 (https://www.fiercepharma.com/collection/fierce-50-2026) includes people and organizations working on very different problems across biopharma and healthcare, from designing new proteins and developing cancer medicines to protecting vaccine science, improving health literacy and expanding representation in medicine.

In this episode of “The Top Line,” Fierce Editor-in-Chief Ayla Ellison looks at the stories behind several of this year’s honorees, including Revolution Medicines’ work targeting RAS, the protein-design research of David Baker, Ph.D., and Michael Osterholm, Ph.D.’s, decision to put plans to step back from public health on hold. The episode also explores the work of Lisa Fitzpatrick, M.D., Hip Hop Public Health, Eric Topol, M.D., and Mary Owen, M.D., and the problems they have chosen to keep working on.

See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.

Back to The Top Line · Report a problem